We are live on ! Find out more
NRSN icon

NeuroSense Therapeutics
NRSN

13 hedge funds and large institutions have $287K invested in NeuroSense Therapeutics in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $266K → $287K (+$20.5K)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IAA
Independent Advisor Alliance
North Carolina
+$44.6K
2
Jane Street
Jane Street
New York
+$25.6K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$18.9K
4
UBS Group
UBS Group
Switzerland
+$16.3K

Top Sellers

Rank Fund Capital Flow
1
GS
GTS Securities
New York
-$27.5K
2
YAG
Yorkville Advisors Global
New Jersey
-$19.6K
3
Squarepoint
Squarepoint
New York
-$13.8K
4
Two Sigma Investments
Two Sigma Investments
New York
-$6.34K
5
SS
SBI Securities
Japan
-$1.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
YAG
1
Yorkville Advisors Global
New Jersey
$58.9K -$19.6K -22,000 -22%
IAA
2
Independent Advisor Alliance
North Carolina
$37.8K +$44.6K +50,000 New
UBS Group
3
UBS Group
Switzerland
$37.1K +$16.3K +18,225 +59%
Two Sigma Investments
4
Two Sigma Investments
New York
$33.6K -$6.34K -7,100 -14%
MIH
5
Meitav Investment House
Israel
$30.2K – – –
Jane Street
6
Jane Street
New York
$21.6K +$25.6K +28,670 New
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$17.2K – – –
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$16K +$18.9K +21,150 New
Pathstone Holdings
9
Pathstone Holdings
New Jersey
$12.5K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$12K – – –
Creative Planning
11
Creative Planning
Kansas
$8.99K – – –
Jones Financial Companies
12
Jones Financial Companies
Missouri
$731 – – –
SS
13
SBI Securities
Japan
$200 -$1.06K -1,190 -82%
GS
14
GTS Securities
New York
– -$27.5K -35,753 Closed
Squarepoint
15
Squarepoint
New York
– -$13.8K -17,926 Closed
JWM
16
Jessup Wealth Management
Ohio
– -$385 -500 Closed

NRSN Hedge Fund Activity: Q1 2026 in Review

13 of the 8,147 institutional investors tracked by Wall St. Rank reported a position in NeuroSense Therapeutics (NRSN) for Q1 2026, worth a combined $287K — up 7.7% from $266K a quarter earlier.

Fund positioning in NRSN was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Independent Advisor Alliance, opening a new position worth an estimated $44.6K. The largest seller was GTS Securities, exiting entirely with an estimated $27.5K sold.

  • 13 institutional investors held NeuroSense Therapeutics (NRSN) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $287K of NeuroSense Therapeutics stock for Q1 2026, up 7.7% quarter-over-quarter.
  • 3 funds opened new NeuroSense Therapeutics positions in Q1 2026 and 3 closed out, a net change of 0 holders.
  • The largest NeuroSense Therapeutics buyer in Q1 2026 was Independent Advisor Alliance, an estimated $44.6K added.
  • The largest NeuroSense Therapeutics seller in Q1 2026 was GTS Securities, an estimated $27.5K sold.

Based on aggregated 13F filings for Q1 2026.